HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased serum SIRT6 as a novel predictor of coronary artery disease.

AbstractOBJECTIVE:
SIRT6 is an NAD-dependent histone deacetylase known to regulate aging, inflammation and energy metabolism, and might play an important role in atherosclerosis. However, whether it also plays a role in coronary artery disease (CAD) remains unclear.
PATIENTS AND METHODS:
In this study, we detected the expression of SIRT6 in serum by Western blotting. The concentrations of SIRT6 in serum specimens from 69 patients with CAD [30 with stable angina (SA) and 39 with acute coronary syndrome (ACS)] and 16 controls were analysed using the enzyme-linked immunosorbent assay (ELISA) method.
RESULTS:
Western blotting analysis of the serum samples found that SIRT6 expression was decreased in the SA group (p=0.000) and ACS group (p=0.000) compared with the control group. Significantly lower levels of serum SIRT6 were observed in SA patients (18.80±9.14 ng/mL) and ACS patients (16.85±9.66 ng/mL) than in healthy controls (25.79±14.23 ng/mL). SIRT6 concentrations were positively correlated with other markers of CAD, such as high-density lipoprotein cholesterol (r=0.362, p<0.01) and age (r=0.265, p<0.05), and negatively correlated with blood glucose (r=-0.284, p<0.05). Multivariate logistic regression analysis demonstrated that lower SIRT6 levels were independently associated with the presence of CAD in men (OR=0.817, 95% CI 0.694-0.962, p=0.015). Receiver operating characteristic (ROC) curve analysis showed that lower serum SIRT6 could distinguish CAD patients (AUC, 0.726; 95% CI, 0.508-0.943; p=0.041) from controls. SIRT6 is found downregulated in blood vessels of atherosclerotic APOE-/- mice and human aorta arteries.
CONCLUSIONS:
We demonstrated that SA and ACS patients had lower serum concentrations of SIRT6. The decreased serum SIRT6 level was independently associated with the diagnosis of CAD. SIRT6 may play a cardioprotective role in CAD patients, and future research is required to address this issue.
AuthorsZ Yan, X Wang, Y-S Liu, X-W Xing, X-G Zhang, Q-H Lu
JournalEuropean review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) Vol. 25 Issue 21 Pg. 6660-6669 (Nov 2021) ISSN: 2284-0729 [Electronic] Italy
PMID34787870 (Publication Type: Journal Article)
Chemical References
  • Sirt6 protein, mouse
  • SIRT6 protein, human
  • Sirtuins
Topics
  • Acute Coronary Syndrome (blood, genetics, metabolism)
  • Adult
  • Aged
  • Aged, 80 and over
  • Angina, Stable (blood, genetics, metabolism)
  • Animals
  • Aorta (metabolism)
  • Coronary Artery Disease (blood, genetics, metabolism)
  • Down-Regulation
  • Female
  • Humans
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout, ApoE
  • Middle Aged
  • Retrospective Studies
  • Sirtuins (blood, genetics, metabolism)
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: